VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PROK
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PROKProKidney Corp.
$1.89$268M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPROKQuarterly Financials

ProKidney Corp. (PROK) Quarterly Financials

120+ quarters historyFree accessUpdated daily

ProKidney Corp. (PROK) quarterly income statement — complete revenue, gross profit & net income history

PROK Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue226K225K217K221K230K76K000000
Revenue Growth %-1.74%196.05%----------
Cost of Goods Sold1.44M1.45M0000000000
COGS % of Revenue634.96%644%----------
Gross Profit-1.21M-1.22M217K221K230K76K000000
Gross Margin %-534.96%-544%100%100%100%100%------
Gross Profit Growth %-625.65%-1710.53%----------
Operating Expenses43.72M44.15M38.76M39.93M41.62M51.65M48.97M43.06M40.08M24.21M46.62M39.82M
OpEx % of Revenue19346.9%19620.89%17859.91%18067.87%18094.78%67956.58%------
Selling, General & Admin11.32M6.26M11.94M14.05M14.36M11.87M17.72M13.65M12.84M1.68M14.42M13.46M
SG&A % of Revenue5007.52%2784%5500%6356.56%6241.3%15613.16%------
Research & Development33.84M34.16M26.82M25.88M27.26M39.78M31.25M29.4M27.23M22.53M32.2M26.36M
R&D % of Revenue14974.34%15180.89%12359.91%11711.31%11853.48%52343.42%------
Other Operating Expenses-1000K1000K0000000000
Operating Income-44.93M-45.37M-38.54M-39.71M-41.39M-51.57M-48.97M-43.06M-40.08M-24.21M-46.62M-39.82M
Operating Margin %-19881.86%-20164.89%-17759.91%-17967.87%-17994.78%-67856.58%------
Operating Income Growth %-8.57%12.02%21.31%7.77%-3.27%-113.02%-5.05%-8.13%1.96%19.93%-31.05%-92.01%
EBITDA-43.5M-43.92M-36.87M-38.24M-39.79M-50M-47.49M-41.79M-38.97M-23.06M-45.61M-38.95M
EBITDA Margin %-19246.9%-19520.89%-16988.94%-17304.98%-17299.13%-65785.53%------
EBITDA Growth %-9.32%12.15%22.37%8.48%-2.09%-116.78%-4.11%-7.28%2.67%21.67%-31.11%-94.88%
D&A (Non-Cash Add-back)1.44M1.45M1.67M1.47M1.6M1.57M1.49M1.27M1.1M1.15M1M870K
EBIT-44.93M-45.37M-35.28M-36.12M-37.36M-46.78M-43.39M-38.52M-35.23M-18.93M-41.08M-33.85M
Net Interest Income2.31M2.93M3.26M3.59M4.03M4.79M5.58M4.53M4.84M5.28M5.54M5.96M
Interest Income2.33M2.94M3.26M3.59M4.03M4.79M5.58M4.54M4.84M5.28M5.54M5.96M
Interest Expense15K1K2K1K02K2K3K2K3K2K4K
Other Income/Expense2.31M2.93M3.26M3.59M4.03M4.79M5.58M4.53M4.84M5.28M5.54M5.96M
Pretax Income-42.62M-42.44M-35.28M-36.12M-37.36M-46.78M-43.4M-38.52M-35.23M-18.93M-41.08M-33.86M
Pretax Margin %-18858.85%-18860.89%-16259.45%-16342.53%-16243.91%-61553.95%------
Income Tax-20.04M-1.58M560K848K591K1.7M-2.34M-56K98K2.79M913K965K
Effective Tax Rate %47.01%3.73%-1.59%-2.35%-1.58%-3.64%5.4%0.15%-0.28%-14.74%-2.22%-2.85%
Net Income-22.58M-19.23M-16.47M-16.55M-16.73M-21.28M-17.91M-12.51M-9.49M-5.7M-10.98M-9.12M
Net Margin %-9992.92%-8547.11%-7589.4%-7489.59%-7275.65%-27997.37%------
Net Income Growth %-34.96%9.62%8.05%-32.35%-76.3%-273.23%-63.06%-37.16%1.79%12.12%7.91%58.8%
Net Income (Continuing)-22.58M-40.85M-35.84M-36.97M-37.95M-48.48M-41.05M-38.47M-35.33M-21.72M-41.99M-34.82M
Discontinued Operations000000000000
Minority Interest1.29B1.31B1.33B1.34B1.37B1.4B1.42B1.44B1.46B1.49B1.52B1.78B
EPS (Diluted)-0.16-0.14-0.12-0.13-0.13-0.17-0.14-0.16-0.16-0.10-0.18-0.14
EPS Growth %-23.08%17.65%14.29%18.75%18.75%-78.57%22.22%-14.29%73.33%76.2%-38.46%61.11%
EPS (Basic)-0.16-0.14-0.12-0.13-0.13-0.17-0.14-0.16-0.16-0.10-0.18-0.14
Diluted Shares Outstanding141.93M134.99M134.99M130.73M128.98M128.05M126.17M75.91M60.95M59.88M61.59M64.56M
Basic Shares Outstanding141.93M134.99M134.99M130.73M128.98M128.05M126.17M75.91M60.95M59.88M61.59M64.56M
Dividend Payout Ratio------------